Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
—
42.09%
80%
—
—
80%
—
5 Years
Score—
Net Growth42.09%
Net Trend80%
Net Income Consistency—
Rev Growth—
Rev Trend80%
Revenue Consistency—
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.23 | — |
1 Year2025-08-12 | $ 2.94 | -58.16% |
5 Years2021-08-12 | $ 26.50 | -95.36% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 |
|---|---|---|---|
| Price | $ 1.23 | $ 2.94 | $ 26.50 |
| Return | — | -58.16% | -95.36% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 81M | -$ 142M | $ 261M |
| 2024 | $ 70M | -$ 157M | $ 250M |
| 2023 | $ 69M | -$ 240M | $ 278M |
| 2022 | $ 209M | -$ 157M | $ 326M |
| 2021 | $ 33M | -$ 230M | $ 466M |
| 2020 | $ 0.00 | -$ 246M | $ 439M |
| 2019 | $ 2M | -$ 116M | $ 115M |
| 2018 | $ 1M | -$ 123M | $ 138M |
| 2017 | $ 1M | -$ 89M | $ 262M |
| 2016 | $ 143M |
Explore beyond ADCT
You're looking at ADC Therapeutics SA. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
